Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Pfizer
Pfizer
Pfizer's Sutent fails in lung cancer study
Yahoo/AP
Mon, 08/23/10 - 07:19 pm
Pfizer
Sutent
lung cancer
Renegade Researcher Says Alzheimer’s Drugs From Bristol-Myers, Pfizer May Be Unsafe Or Ineffective
Forbes
Mon, 08/23/10 - 10:06 am
Pfizer
Alzheimer's disease
Bristol-Myers Squibb
anti-amyloid
Eli Lilly
Patients Should Stay on Pfizer's Lipitor, Not Switch to Generic, Study Says
Bloomberg
Mon, 08/23/10 - 09:29 am
statins
Pfizer
cholesterol
Lipitor
generics
Once Again, Preemption Is Not A Defense For Wyeth
Pharmalot
Mon, 08/23/10 - 09:20 am
Wyeth
preemption
FDA
Redux
Pfizer
Eli Lilly Setback Could Pave Way For New Alzheimer’s Approach
Forbes
Fri, 08/20/10 - 12:45 pm
Eli Lilly
Alzheimer's disease
Pfizer
Elan
Bristol-Myers Squibb
Pfizer Menopause Drug Didn't Cause Cancers, Jury Says
Bloomberg
Thu, 08/19/10 - 10:34 am
Pfizer
HRT
cancer
Prempro
Wyeth
Lilly's Alzheimer's disaster spells trouble for entire class
Fierce Biotech
Wed, 08/18/10 - 10:06 am
Eli Lilly
Alzheimer's disease
Elan
Bristol-Myers Squibb
JNJ
Pfizer
Dumped in a Parking Lot: How Pfizer Fires Sales Reps It Doesn’t Like
BNET Pharma
Wed, 08/18/10 - 07:42 am
Pfizer
drug reps
firings
Big Pharma's Big Problem
Investopedia
Mon, 08/16/10 - 06:11 pm
Biogen Idec
Bristol-Myers Squibb
Genzyme
Pfizer
Sanofi
Affymetrix
Pfizer Fights Back Against Forbes
Forbes
Mon, 08/16/10 - 09:59 am
Pfizer
cancer
Virtual Biotechs Are Here to Stay
Seeking Alpha
Sun, 08/15/10 - 11:42 am
Eli Lilly
Ranbaxy
Pfizer
Vaccine sales up 16 pct in 2009, still growing
Yahoo/AP
Sat, 08/14/10 - 12:36 pm
vaccines
Merck
GSK
Pfizer
Novartis
Sanofi
US probes corruption in big pharma
FT.com
Fri, 08/13/10 - 07:27 am
DOJ
Merck
GSK
Pfizer
Bristol-Myers Squibb
Eli Lilly
SEC
Pfizer: Strengths, Weaknesses, Opportunities, Threats
Motley Fool
Thu, 08/12/10 - 10:07 pm
Pfizer
FDA panel favors Glaxo epilepsy drug
Yahoo/AP
Wed, 08/11/10 - 05:38 pm
GSK
epilepsy
Potiga
FDA
advisory panels
JNJ
Pfizer
Valeant Pharmaceuticals
When the Disease Matters Most in Drug Approval
Motley Fool
Wed, 08/11/10 - 11:08 am
drug development
JNJ
Vivus
Valeant Pharmaceuticals
GSK
Pfizer
Abbott Laboratories
Medivation Narrows Loss
Yahoo/Zacks.com
Wed, 08/11/10 - 09:10 am
earnings
Medivation
Pfizer
AstraZeneca
Two IPOs Brave the Markets, Two Enter the Queue: Biotech's Latest Deals
Seeking Alpha
Sun, 08/8/10 - 01:18 pm
Trius Therapeutics
Torezolid
Pfizer
linezolid
skin infection
NuPathe
Zelrix
migraines
Complete Genomics
Horizon Pharma
Pfizer's quarter could mark a comeback
The Day, CT
Sun, 08/8/10 - 12:55 pm
Pfizer
investors
CyDex Pharmaceuticals licenses compound that could expand market reach Read more: CyDex Pharmaceuticals licenses compound that could expand market reach - Kansas City Business Journal
bizjournals
Sat, 08/7/10 - 11:59 am
CyDex Pharmaceuticals
Captisol
Pfizer
Bristol-Myers Squibb
Prism Pharmaceuticals
Pages
« first
‹ previous
…
273
274
275
276
277
278
279
280
281
…
next ›
last »